IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 135 filers reported holding IMMUNOVANT INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $21,558,900 | -67.1% | 1,390,000 | -62.4% | 0.40% | -69.4% |
Q4 2022 | $65,563,530 | +118.7% | 3,693,720 | -31.2% | 1.29% | +119.2% |
Q3 2022 | $29,979,000 | +43.1% | 5,372,512 | 0.0% | 0.59% | +31.7% |
Q2 2022 | $20,953,000 | -29.2% | 5,372,512 | 0.0% | 0.45% | -3.4% |
Q1 2022 | $29,603,000 | -29.8% | 5,372,512 | +8.5% | 0.46% | -13.9% |
Q4 2021 | $42,174,000 | -2.0% | 4,950,000 | 0.0% | 0.54% | -4.9% |
Q3 2021 | $43,016,000 | +20.7% | 4,950,000 | +46.8% | 0.57% | +18.4% |
Q2 2021 | $35,631,000 | -10.2% | 3,370,994 | +36.3% | 0.48% | -18.5% |
Q1 2021 | $39,667,000 | -7.9% | 2,473,000 | +165.3% | 0.59% | -10.9% |
Q4 2020 | $43,049,000 | +31.3% | 932,000 | 0.0% | 0.66% | +2.8% |
Q3 2020 | $32,797,000 | +115.2% | 932,000 | +48.9% | 0.64% | +94.0% |
Q2 2020 | $15,242,000 | – | 625,950 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 1,500,000 | $26,625 | 8.85% |
Deep Track Capital, LP | 9,710,000 | $172,352,500 | 7.24% |
Logos Global Management LP | 3,150,000 | $55,912,500 | 6.55% |
Ikarian Capital, LLC | 966,700 | $17,158,925 | 4.14% |
COMMODORE CAPITAL LP | 1,150,505 | $20,421 | 3.08% |
TCG Crossover Management, LLC | 854,853 | $15,173,641 | 2.68% |
SILVERARC CAPITAL MANAGEMENT, LLC | 519,614 | $9,223,149 | 2.64% |
COWEN AND COMPANY, LLC | 1,250,000 | $22,187,500 | 2.32% |
BVF INC/IL | 2,561,000 | $45,457,750 | 1.92% |
Eventide Asset Management | 3,693,720 | $65,563,530 | 1.29% |